Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2019 Mar;17(2):163-164.
doi: 10.2450/2019.0237-18. Epub 2019 Jan 21.

Dabigratan-related acute agranulocytosis

Affiliations
Comment

Dabigratan-related acute agranulocytosis

Ahmad Al-Khaffaf et al. Blood Transfus. 2019 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The Authors declare no conflicts of interest.

Comment on

References

    1. Schiavoni M, Margaglione M, Coluccia A. Use of dabigatran and rivaroxaban in non-valvular atrial fibrillation: one-year follow-up experience in an Italian centre. Blood Transfus. 2018;16:209–14. - PMC - PubMed
    1. Steffel J, Verhamme P, Potpara TS, et al. ESC Scientific Document Group. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J. 2018;39:1330–93. - PubMed
    1. Tripodi A, Ageno W, Ciaccio M, et al. Position Paper on laboratory testing for patients on direct oral anticoagulants. A Consensus Document from the SISET, FCSA, SIBioC and SIPMeL. Blood Transfus. 2018;16:462–70. - PMC - PubMed
    1. Hayashi H, Kitoh K, Mitsunami K, et al. Agranulocytosis immediately oral admistraion cibenzoline and dabigatran in a patient with paroxysmal atrial fibrillation. Intern Med. 2012;51:1987–90. - PubMed
    1. Fasullo S, Davì S, Cosenza G, et al. Acute agranulocytosis after oral administration of dabigatran: a rare case report and a short literature review. J Thromb Thrombolysis. 2018;45:588–92. - PubMed